Working… Menu

Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02188693
Recruitment Status : Unknown
Verified July 2014 by LiNanlin,Ph.D, Chief Physician,Clinical Professor, Xijing Hospital.
Recruitment status was:  Recruiting
First Posted : July 14, 2014
Last Update Posted : July 14, 2014
Eli Lilly and Company
Information provided by (Responsible Party):
LiNanlin,Ph.D, Chief Physician,Clinical Professor, Xijing Hospital

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : July 2017
Estimated Study Completion Date : December 2017